| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial
|
Meattini, Icro
|
|
2017
|
76 |
C |
p. 17-26
10 p.
|
artikel
|
| 2 |
A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study
|
Ravaud, Alain
|
|
2017
|
76 |
C |
p. 110-117
8 p.
|
artikel
|
| 3 |
A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours
|
de Jonge, Maja
|
|
2017
|
76 |
C |
p. 144-151
8 p.
|
artikel
|
| 4 |
Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma
|
Moy, Jennifer D.
|
|
2017
|
76 |
C |
p. 152-166
15 p.
|
artikel
|
| 5 |
Cancer immunotherapy targeting the CD47/SIRPα axis
|
Weiskopf, Kipp
|
|
2017
|
76 |
C |
p. 100-109
10 p.
|
artikel
|
| 6 |
Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients
|
Farag, Sheima
|
|
2017
|
76 |
C |
p. 76-83
8 p.
|
artikel
|
| 7 |
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials
|
George, Angela
|
|
2017
|
76 |
C |
p. 52-59
8 p.
|
artikel
|
| 8 |
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
|
Palmerini, E.
|
|
2017
|
76 |
C |
p. 118-124
7 p.
|
artikel
|
| 9 |
Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients
|
Kraal, K.C.J.M.
|
|
2017
|
76 |
C |
p. 188-196
9 p.
|
artikel
|
| 10 |
Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial
|
Twelves, Chris
|
|
2017
|
76 |
C |
p. 205-215
11 p.
|
artikel
|
| 11 |
Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG)
|
Kasper, Bernd
|
|
2017
|
76 |
C |
p. 60-67
8 p.
|
artikel
|
| 12 |
Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria
|
Martin, Jacob A.
|
|
2017
|
76 |
C |
p. 197-204
8 p.
|
artikel
|
| 13 |
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group
|
Kwakman, Johannes J.M.
|
|
2017
|
76 |
C |
p. 93-99
7 p.
|
artikel
|
| 14 |
Influenza vaccination in adult patients with solid tumours treated with chemotherapy
|
Vollaard, Albert
|
|
2017
|
76 |
C |
p. 134-143
10 p.
|
artikel
|
| 15 |
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies
|
Del Rio, M.
|
|
2017
|
76 |
C |
p. 68-75
8 p.
|
artikel
|
| 16 |
Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity
|
Lee, Jong-chan
|
|
2017
|
76 |
C |
p. 125-133
9 p.
|
artikel
|
| 17 |
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
|
Stacchiotti, S.
|
|
2017
|
76 |
C |
p. 84-92
9 p.
|
artikel
|
| 18 |
Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer
|
Massard, Christophe
|
|
2017
|
76 |
C |
p. 36-44
9 p.
|
artikel
|
| 19 |
Preoperative radiotherapy in breast cancer patients: 32 years of follow-up
|
Riet, F.G.
|
|
2017
|
76 |
C |
p. 45-51
7 p.
|
artikel
|
| 20 |
Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation
|
Zschäbitz, Stefanie
|
|
2017
|
76 |
C |
p. 1-7
7 p.
|
artikel
|
| 21 |
Rituximab maintenance improves overall survival of patients with follicular lymphoma—Individual patient data meta-analysis
|
Vidal, Liat
|
|
2017
|
76 |
C |
p. 216-225
10 p.
|
artikel
|
| 22 |
Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis
|
Le Bras, Fabien
|
|
2017
|
76 |
C |
p. 183-187
5 p.
|
artikel
|
| 23 |
Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancers
|
Petrelli, Fausto
|
|
2017
|
76 |
C |
p. 8-16
9 p.
|
artikel
|
| 24 |
The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma
|
van der Kaaij, Rosa T.
|
|
2017
|
76 |
C |
p. 27-35
9 p.
|
artikel
|
| 25 |
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
|
Brochez, Lieve
|
|
2017
|
76 |
C |
p. 167-182
16 p.
|
artikel
|
Tijdschrift beschrijving